The Food and Drug Administration Wednesday abruptly and unexpectedly cancelled a planned March 13 vaccine advisory committee meeting that was to have chosen the flu strains in next year's U.S. flu ...
Conference call and webcast at 8:00 a.m. ET NEW YORK, March 27, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for ...
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...
Genentech Provides Update on FDA Advisory Committee Meeting on Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma - Columvi is the first bispecific antibody to ...
Overall, 82%, 11%, and 7% of speakers supported drug approval, opposed approval, and were neutral, respectively. (HealthDay News) — Most speakers attending US Food and Drug Administration (FDA) Human ...
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from ...
The researchers found that 48% of speakers are patients and family members, 99% of whom support drug approval. HealthDay News — Most speakers attending US Food and Drug Administration (FDA) Human Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results